Irinotecan and 5-Fluorouracil in colorectal cancer: time for a pause?

This publication has 22 references indexed in Scilit:

• Sister chromatid exchange induced by DNA topoisomerases poisons in late replicating heterochromatin: influence of inhibition of replication and transcription
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996
• CPT-11 (Irinotecan) in the treatment of colorectal cancer
  European Journal Of Cancer, 1995
• Cellular Determinants of Sensitivity and Resistance to DNA Topoisomerase Inhibitors
  Cancer Investigation, 1994
• Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
  Journal of Clinical Oncology, 1993
• Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1992
• Effects of CPT‐11 in combination with other anti‐cancer agents in culture
  International Journal of Cancer, 1992
• Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA
  Nucleic Acids Research, 1991
• DNA Topoisomerase I—Targeted Chemotherapy of Human Colon Cancer in Xenografts
  Science, 1989
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.
  Molecular and Cellular Biology, 1988